These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 24157688)

  • 1. Identification of a treatment-resistant, ketamine-sensitive genetic line in the chick anxiety-depression model.
    Sufka KJ; White SW
    Pharmacol Biochem Behav; 2013 Nov; 113():63-7. PubMed ID: 24157688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain-derived neurotrophic factor response in vulnerable and resilient genetic lines in the chick anxiety-depression model.
    Loria MJ; White SW; Robbins SA; Salmeto AL; Hymel KA; Murthy SN; Manda P; Sufka KJ
    Behav Brain Res; 2013 May; 245():29-33. PubMed ID: 23396147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anxiolytic-like effects of an mGluR 5 antagonist and a mGluR 2/3 agonist, and antidepressant-like effects of an mGluR 7 agonist in the chick social separation stress test, a dual-drug screening model of treatment-resistant depression.
    White SW; Squires GD; Smith SJ; Wright GM; Sufka KJ; Rimoldi JM; Gadepalli RS
    Pharmacol Biochem Behav; 2023 Jun; 227-228():173588. PubMed ID: 37348610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antidepressant efficacy screening of novel targets in the chick anxiety-depression model.
    Sufka KJ; Warnick JE; Pulaski CN; Slauson SR; Kim YB; Rimoldi JM
    Behav Pharmacol; 2009 Mar; 20(2):146-54. PubMed ID: 19300238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strain vulnerability and resiliency in the chick anxiety-depression model.
    Hymel KA; Salmeto AL; Loria MJ; White SW; Sufka KJ
    Physiol Behav; 2013 Aug; 120():124-9. PubMed ID: 23911807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of Sceletium tortuosum (L.) N.E. Br. extract fraction in the chick anxiety-depression model.
    Carpenter JM; Jourdan MK; Fountain EM; Ali Z; Abe N; Khan IA; Sufka KJ
    J Ethnopharmacol; 2016 Dec; 193():329-332. PubMed ID: 27553978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modelling the anxiety-depression continuum in chicks.
    Warnick JE; Huang CJ; Acevedo EO; Sufka KJ
    J Psychopharmacol; 2009 Mar; 23(2):143-56. PubMed ID: 18515452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling the anxiety-depression continuum hypothesis in domestic fowl chicks.
    Sufka KJ; Feltenstein MW; Warnick JE; Acevedo EO; Webb HE; Cartwright CM
    Behav Pharmacol; 2006 Dec; 17(8):681-9. PubMed ID: 17110794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The positive effect on ketamine as a priming adjuvant in antidepressant treatment.
    Melo A; Kokras N; Dalla C; Ferreira C; Ventura-Silva AP; Sousa N; Pêgo JM
    Transl Psychiatry; 2015 May; 5(5):e573. PubMed ID: 26080090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of environmental enrichment in the chick anxiety-depression model.
    Kim EH; Sufka KJ
    Behav Brain Res; 2011 Aug; 221(1):276-81. PubMed ID: 21402107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological reversal of cognitive bias in the chick anxiety-depression model.
    Hymel KA; Sufka KJ
    Neuropharmacology; 2012 Jan; 62(1):161-6. PubMed ID: 21722654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ketamine plus imipramine treatment induces antidepressant-like behavior and increases CREB and BDNF protein levels and PKA and PKC phosphorylation in rat brain.
    Réus GZ; Stringari RB; Ribeiro KF; Ferraro AK; Vitto MF; Cesconetto P; Souza CT; Quevedo J
    Behav Brain Res; 2011 Aug; 221(1):166-71. PubMed ID: 21397634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of AMPA receptor in both the rapid and sustained antidepressant-like effects of ketamine in animal models of depression.
    Koike H; Iijima M; Chaki S
    Behav Brain Res; 2011 Oct; 224(1):107-11. PubMed ID: 21669235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioral, endocrine, and neuronal alterations in zebrafish (Danio rerio) following sub-chronic coadministration of fluoxetine and ketamine.
    Pittman J; Hylton A
    Pharmacol Biochem Behav; 2015 Dec; 139 Pt B():158-62. PubMed ID: 26303305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antidepressant-like effects of glutamatergic drugs ketamine and AMPA receptor potentiator LY 451646 are preserved in bdnf⁺/⁻ heterozygous null mice.
    Lindholm JS; Autio H; Vesa L; Antila H; Lindemann L; Hoener MC; Skolnick P; Rantamäki T; Castrén E
    Neuropharmacology; 2012 Jan; 62(1):391-7. PubMed ID: 21867718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening antidepressants in the chick separation-stress paradigm.
    Feltenstein MW; Sufka KJ
    Psychopharmacology (Berl); 2005 Aug; 181(1):153-9. PubMed ID: 15778882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluoxetine attenuates the anxiolytic effects of the probiotic VSL#3 in a stress-vulnerable genetic line of aves in the chick social-separation stress test, a dual screening assay.
    White SW; Callahan H; Smith SJ; Padilla FM
    Pharmacol Biochem Behav; 2024 Sep; 245():173880. PubMed ID: 39277109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anxiolytic- and antidepressant-like properties of ketamine in behavioral and neurophysiological animal models.
    Engin E; Treit D; Dickson CT
    Neuroscience; 2009 Jun; 161(2):359-69. PubMed ID: 19321151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modeling anxiety-like states: pharmacological characterization of the chick separation stress paradigm.
    Warnick JE; Wicks RT; Sufka KJ
    Behav Pharmacol; 2006 Nov; 17(7):581-7. PubMed ID: 17021390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The WAG/Rij strain: a genetic animal model of absence epilepsy with comorbidity of depression [corrected].
    Sarkisova K; van Luijtelaar G
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun; 35(4):854-76. PubMed ID: 21093520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.